Equine Familial Isolated Hypoparathyroidism (EFIH)
Gene or Region: RAPGEF5
Reference Variant: C
Mutant Variant: A
Affected Breeds: Thoroughbred, Thoroughbred crosses, other Thoroughbred-influenced breeds
Research Confidence: High - Strong association in studied population
Explanation of Results: efih/efih = homozygous for Equine Familial Isolated Hypoparathyroidism, trait expressed efih/n = heterozygous for Equine Familial Isolated Hypoparathyroidism, carrier n/n = no variant detected
Equine Familial Isolated Hypoparathyroidism (EFIH): What You Need to Know Before Breeding Thoroughbreds
Equine Familial Isolated Hypoparathyroidism (EFIH) is a fatal genetic disorder identified in Thoroughbred foals, characterized by low blood calcium levels leading to muscle stiffness, seizures, and, ultimately, death. The condition is inherited in an autosomal recessive manner, meaning that foals with two copies of the causative genetic variant are affected.
EFIH manifests in foals up to 35 days old, presenting with symptoms such as involuntary muscle contractions, a stiff gait progressing to an inability to stand, seizures, fever, and rapid pulse. These clinical signs are associated with low blood calcium concentrations and inadequately low or normal parathyroid hormone levels. Necropsy findings often reveal underdeveloped or absent parathyroid glands.
Gene Information
The genetic basis for EFIH is a nonsense variant in the Rap Guanine Nucleotide Exchange Factor 5 gene (RAPGEF5) that replaces a serine in the protein product with a stop codon (c.2624C>A p.Ser875*), leading to a truncated protein with decreased functionality. RAPGEF5 plays a crucial role in intracellular signaling pathways, particularly those involved in cyclic AMP (cAMP)-dependent signaling and calcium homeostasis. In affected horses, this variant in RAPGEF5 disrupts normal parathyroid gland function, impairing PTH synthesis and secretion.
References
Rivas, V. N., Magdesian, K. G., Fagan, S., Slovis, N. M., Luethy, D., Javsicas, L. H., Caserto, B. G., Miller, A. D., Dahlgren, A. R., Peterson, J., Hales, E. N., Peng, S., Watson, K. D., Khokha, M. K., & Finno, C. J. (2020). A nonsense variant in Rap Guanine Nucleotide Exchange Factor 5 (RAPGEF5) is associated with equine familial isolated hypoparathyroidism in Thoroughbred foals. PLoS Genetics, 16(9), e1009028. doi: 10.1371/journal.pgen.1009028
More Horse Health
Equine Herpes Virus Type 1 & Induced Myeloencephalopathy
Equine herpesviruses are DNA viruses that are found in most horses all over the world, often without any serious side effects. Following infection of Equine Herpesvirus Type 1 (EHV-1) some horses then suffer Equine Herpesvirus Myeloencephalopathy (EHM), which is is accompanied by serious and sometimes fatal neurological effects. EHM in horses can have serious neurological symptoms on affected horses.
Equine Metabolic Syndrome / Laminitis Risk
Equine Metabolic Syndrome (EMS) is a wide-spread issue in the horse population. Primarily characterized by hyperinsulinemia (excess insulin circulating in the blood in relation to glucose levels), this metabolic disorder is often present in obese horses and ponies and can be challenging to diagnose as it can be misdiagnosed as "Cushing's" (a pituitary disfunction).
Equine Recurrent Uveitis Risk and Severity
Equine Recurrent Uveitis (ERU) is the most common cause of blindness in horses, affecting about 3-15% of the horse population worldwide. Characterized by episodes of inflammation of the middle layer of the eye, Equine Recurrent Uveitis in horses leads to the development of cataracts, glaucoma and eventually complete loss of vision.